We treat all severities of ADHD with a keen focus on the upper limit of FDA-recommended stimulant doses. We prioritize holistic care, viewing our patients as individuals with unique needs.

Qelbree, a relatively new addition to the non-stimulant category, offers a promising alternative with its FDA approval for both children and adults.

At Philadelphia Integrative Psychiatry, we are dedicated to providing our patients with the most effective and personalized care, guided by the latest research in the field of mental health.